BZAI compared with TLX: revenue, margins and what each company keeps, and the suppliers and customers both name

BZAIBlaize Holdings, Inc.

Mkt capRevenueRevenue

TLXTelix Pharmaceuticals Ltd

Mkt capRevenueRevenue

Compare

BZAIBlaize Holdings, Inc.

TLXTelix Pharmaceuticals Ltd

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

BZAI

2 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±24.6%▼−49.31%×2.00

May 15 '26±18.0%▼−25.99%×1.44

Apr 15 '26±17.0%▼−6.25%×0.37

Q1 FY26±32.1%▲+11.71%×0.36

TLX1 of 4 reports

Reportimpliedrealized× implied

Oct 21 '26—▼−10.13%—

= impliedBZAI realized, solidTLX realized, hatchedOne scale, both sides: full bar = 50%× = |realized| ÷ impliedSource: market data

BZAIBlaize Holdings, Inc.

0.20▼−0.40%· post 0.20

Mkt cap$28.3MRevenue$12MQ2 FY26Revenue$39MFY25

TLXTelix Pharmaceuticals Ltd

9.10▼−4.28%· post 9.09

ClosedOct 30 '26

Mkt cap$3.1BRevenue—Revenue—

Compare

ClosedOct 30 '26

BZAIBlaize Holdings, Inc.

TLXTelix Pharmaceuticals Ltd

0.20▼−0.40%post 0.20

Price

9.10▼−4.28%post 9.09

$28.3M

Mkt cap

$3.1B

Q2 FY26$12M

Revenue

—

FY25$39M

Revenue

—

BZAI0.20▼−0.40%vsTLX9.10▼−4.28%ClosedOct 30 '26